News
New Retinal Pigment Epithelial Cell Model to Unravel Neuroprotection Sensors of Neurodegeneration in Retinal Disease. Frontiers in Neuroscience , 2022; 16 DOI: 10.3389/fnins.2022.926629 Cite This ...
Human iPSCs forming a two-dimensional layer generate in vitro retinal pigment epithelial cells, which are pigmented and display typical cobblestone morphology. Hexagonal morphology and ...
FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age ...
National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...
A team of scientists in Singapore has discovered new behavior in transplanted stem cell derived retinal pigment epithelial (RPE ... resembled healthy adult human RPE cells, which play a vital ...
NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related ...
human retinal organoids, stem cell-derived retinal pigment epithelial cells, human retinas, and human retinal pigment epithelial cells. This comprehensive approach provides very strong evidence ...
A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye disorder. But more work is needed to translate the treatment to people.
Healios, Sumitomo begin phase I/II trial of allogeneic iPS cells in retinal pigment epithelium tears
Japan’s Pharmaceutical and Medical Devices Agency has cleared Healios K.K. and Sumitomo Pharma Co. Ltd. to begin a phase I/II study of HLCR-011, which is composed of retinal pigment epithelial (RPE) ...
NIH Scientists Test in an Animal Model a Surgical Technique to Improve Cell Therapy for Dry Age-Related Macular Degeneration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results